Using a small cell lung cancer (SCLC) cDNA library, we obtained clones for the creatine kinase-B (CK-B) gene and determined the nucleotide sequence for the protein coding and 3' untranslated region (3' UT). The human translated protein spans 381 residues and the amino acid homology with rabbit CK-B is > 98%. We have demonstrated that a nucleic acid probe encompassing the protein coding region will also hybridize to CK-M sequences while a probe derived from the 3' UT region is CK-B specific. When a B-isoenzyme specific sequence is hybridized to Eco RI cut genomic DNA, two independent restriction fragment polymorphisms are detected. We have subsequently localized these two CK-B homologous sequences to chromosomes 14q32 and 16. Finally, we show that increased levels ofCK-B seen in SCLC are not accompanied by gene amplification or rearrangement, but reflect a greatly enhanced level of CK-B specific mRNA that is not seen in non-SCLC lines thus far examined.
Introduction
The creatine kinases are a family of enzymes with a highly conserved protein sequence, which are involved in the maintenance of ATP at sites of cellular work (1) . Three cytoplasmic (nonmitochondrial) isoenzymes of creatine kinase (CK)' are readily identified in human tissue. These isoenzymes are dimeric molecules with two dissociable subunits designated as M-(muscle) or B-(brain) type that can reassociate to form the electrophoretically distinct MM, BB, or MB isotypes. Recent investigations have determined that the amino acid sequences of these two subunits are encoded by distinct genes (2, 3) . Despite the existence of CK-M or CK-B cyclic complementary DNA (cDNA) clones from several animal species (2) (3) (4) (5) (6) (7) (8) , the basis for the tissue specific expression of these isoenzymes is not known.
Elevated levels ofthe BB isoenzyme ofCK have been detected in tumor samples obtained from patients with small cell lung cancer (SCLC) (9) . Marked elevation of the BB isoenzyme of CK, as measured with a radioimmunoassay, was previously noted in 49/50 cell lines established in our laboratory from patients with SCLC (10) . In contrast, CK-BB levels in non-SCLC lines were considerably lower or negligible in most cases. The level of this enzyme thus is a reliable marker of SCLC and may be of functional importance in determining aspects ofthe small cell phenotype, including the neuroendocrine features unique to this tumor (1 1) .
In this study we have cloned and sequenced a cDNA copy of the messenger (mRNA) for the human B-isoenzyme of CK from a cDNA library prepared from a SCLC cell line. We have demonstrated that the coding region of this clone will crosshybridize with both M-and B-type isoenzymes. Using a prepared fragment from the 3' untranslated region as a CK-B-specific sequence, we have then examined expression in RNA of the creatine kinase gene in cell lines representing different histologic types oflung cancer. We have also investigated the arrangement ofthis gene in genomic DNA. Two independent, high-frequency Eco RI polymorphic sites were identified that we relate to two CK-B specific sequences located on different chromosomes.
Methods
Cell lines and cell culture. The SCLC cell lines were established from clinically derived specimens by propagation in selective media as described previously (10) . Human promyelocytic cell line HL60 was obtained from J. Trepel, National Cancer Institute, Bethesda, MD. Isolation of cDNA and genomic clones. A SCLC cDNA library in lambda gtlO was constructed from poly (A)-selected RNA isolated from cell line NCI-H378, as described previously (12) , and was screened with a cloned rabbit CK-B cDNA probe described by Pickering and Schimmel (2) and kindly provided by G. Daouk. Several non-full length human cDNA clones were isolated, the largest measuring 1.1 kb. Additional 5' cDNA sequence was obtained by primer extension as described by Cooper and Ordahl (13) . Genomic CK-B specific clones were isolated by screening a partial Mbo I-digested human placental library in Charon phage 28A with a subclone from the most 5' region of the human cDNA sequence. Nucleotide sequence of both strands of cDNA, employing the Sanger dideoxynucleotide chain termination method, were obtained with overlapping Ml 3 phage clones (14, 15) . Due to the lack of useful restriction enzyme sites toward the 3' end of the cDNA clones, overlapping Bal 31 digested Ml3 phage clones were generated for sequencing (16) .
Nucleic acids. DNA, total RNA, and poly (A)-selected RNA were extracted from the human lung cancer cell lines as previously described (17) (18) (19) . In addition, total RNA was extracted from human skeletal muscle obtained at autopsy. DNA and RNA were transferred to nitrocellulose after electrophoresis through nondenaturing or formaldehyde containing gels, respectively (20, 21 (24, 25) . The protected regions of our RNA probe were identified by denaturing 6% acrylamide electrophoresis and autoradiography.
Chromosomal mapping. Localization of the CK-B gene was performed by examination of DNA extracted from a panel of human-rodent somatic cell hybrids. These methods have been previously described in detail (26) .
Results
Human CK-B cDNA sequence. The restriction map and sequencing strategy for the human CK-B cDNA is shown in Fig.  1 . The cDNA sequence ofthe human CK-B protein coding and 3' UT is presented in Fig. 2 . As demonstrated from prior sequence analysis in different animal species (2) (3) (4) (5) (6) (7) (8) , there is remarkable evolutionary conservation in the primary structure of the coding region of the B-subunit from human and rabbit sources. There is a single long open reading frame, in both human and rabbit cDNAs, beginning with an ATG start codon at position 9 in Fig. 2 (Fig. 2) . In contrast, the 3' UT contains no sequence conservation between the brain and muscle isoenzymes yet persistent interspecies homology between human and rabbit brain sequences. Thus a DNA sequence confined to the 3' UT region could serve as a CK-B specific probe. Accordingly, a 115 bp fragment from the 3' UT of our human cDNA clone (nucleotide position 1142 to 1257) was subcloned.
Tissue specificity ofthe CK-B probe. To determine the specificity of the subcloned probe from the 3' UT, total RNA was prepared from human psoas muscle obtained at autopsy or from a SCLC cell line. As shown in Fig. 3 A, a 1.1-kb fragment designated pCK4, which encompasses over three-quarters of the CK-B protein coding sequence (from nucleotide position 270 to the poly-A tail), hybridizes to a 1.6-kb species present in muscle RNA. In contrast, when equal amounts of total RNA isolated from SM is hybridized to the 3' UT-derived CK-B specific probe, no signal is seen even after a prolonged exposure as shown. To prove further the isoenzyme specificity of the 3' untranslated fragment, a RNAase protection assay was performed as seen in Fig. 3 B (data not shown) . Thus, we conclude by sequence analysis, Northern blot, and RNAase protection experiments that our human clones are B-isoenzyme derived and can be used to explore tissue specific expression of this isoenzyme gene.
CK gene expression in lung cancer. Fig. 4 Fig. 5 shows that, using a 5' cDNA probe overlapping the coding region that would detect CK-B or CK-M species, total and poly (A)-selected RNA from SCLC cell lines NCI-H82 and NCI-H592 again express an abundant 1.6-kb message. In contrast, equal amounts of total and poly (A)-selected RNA from rapidly dividing undifferentiated HL60 cells do not show any expression of CK-B. This result implies that expression of CK-B is not merely correlated with rapid cell growth, as HL60 cells grow as or more rapidly than the lung cancer-derived cell lines. In experiments not shown, it was found that induction ofHL60 differentiation to a monocytic phenotype by dibutyryl cAMP was not accompanied by a significant increase in CK gene expression.
Analysis of CK-B specific RNA expression of a panel of tumor cell lines using total RNA and the antisense 3' untranslated probe is shown in Fig. 6 . All SCLC cell lines screened contain large amounts of CK-B specific mRNA. In contrast, total RNA extracted from the promyelocytic cell line HL60 or from lung cancer cell lines derived from adenocarcinoma, large cell, adenosquamous or squamous carcinoma do not offer appreciable protection ofthe CK-B specific probe. Examination ofthe RNA samples, by ethidium bromide-stained gel electrophoresis, showed no differences in the amount or quality of the RNA preparations used from the different cell lines (data not shown). We therefore conclude that the low levels of CK-B activity in non-SCLC derived tumors or cell lines (9) reflect a decrease in the abundance of CK-B mRNA in these different histologic categories of human lung cancer.
Analysis ofgenomic DNA and evidencefor two CK-B genes. To explore the basis for enhanced CK-B gene expression in SCLC, an effort was made to localize this gene and to examine whether amplification or rearrangement of this locus had occurred. Genomic DNA digested with Eco RI from several lung cancer cell lines was examined with the pCK4 probe that we had previously shown to hybridize with both CK-M and CK-B (Fig. 7 A) . A 27-kb band and two independent, high frequency Eco RI restriction fragment length polymorphisms (RFLP) one pair at 17 and 13 kb and the other at 7.5 and 5.4 kb, are observed in the population of human DNAs examined. We have further investigated these Eco RI RFLPs with an additional panel of23 human DNAs, and have calculated the allelic frequency of the 17-and 13-kb bands at 0.5 and the frequency of the 7.5-and 5.4-kb alleles at 0.15 and 0.85, respectively. We have, in addition, digested normal human genomic DNA (from placenta and spleen) along with similarly prepared DNA from several lung cancer specimens and have not found differences in copy numbers of either of the hybridizing bands for CK-B (data not shown). There is, therefore, no evidence for either rearrangement or amplification ofthe CK gene in SCLC despite extensive evidence of enhanced expression. As seen in Fig. 7 B, the 3' untranslated probe specific for CK-B fails to recognize the 27-kb band, but still hybridizes to both Eco RI polymorphisms (Fig. 7 B) . Restriction endonuclease mapping of four independently isolated CK-B genomic clones excludes the possibility of an Eco RI site within a potential intron in the 3' UT (data not shown). Several small, nonoverlapping probes from the 5' region of the CK-B gene also hybridized to both polymorphisms (data not shown). This strongly suggests the presence of two specific CK-B related sequences in the human genome.
Human chromosomal localization of CK-B hybridizing se- In Hind III digests, the 9 kb and 7.7 kb hybridizing human bands (Fig. 8 A) were well resolved from homologous mouse sequences but the 9-kb band could not be separated from a doublet (9.3 and 8.8 kb) of hybridizing hamster sequences. In Pst I digests (Fig. 8 B) , all four hybridizing human fragments were resolved from hybridizing bands in mouse DNA, but the 5-kb human band was not resolved from a 4.9-kb hybridizing sequence in hamster DNA. The 8.4-kb hybridizing human sequence in Bam HI digests (Fig. 8 C) was resolved from homologous rodent bands but the 24-kb human band intensity was low and it was poorly separated from a 22-kb hamster band.
Analysis of the panel of hybrid cell DNAs reveals that sequences hybridizing to the CK-B probe were located on two different human chromosomes (Table I ). The 2.4-and 7.7-kb human Hind III bands and the 0.95-and 1.55-kb human Pst I bands always segregated concordantly and were detected only in hybrid cells that contained the 8.4-kb Bam HI human band. These CK-B hybridizing sequences, designated CK-Bl, could be localized to the specific human chromosomal band 14q32. This localization was obtained by analysis ofa group of hybrids that were isolated after fusing human fibroblasts containing a well characterized reciprocal chromosome translocation (Xql3;14q32) with Chinese hamster fibroblasts (27) . Two of these hybrids retained the human 14/X translocation chromosome but no human CK-Bl sequences (Fig. 8 C, lane 2) while the other three hybrids retained these CK-BI sequences and the human X/14 translocation chromosome but neither an intact chromosome 14 nor the 14/X reciprocal translocation chromosome. Human CK-BB isoenzyme activity and the heavy chain immunoglobulin locus (IgH) (27) also cosegregated with the now designated CK-Bl sequence in these hybrids. These results permit unambiguous assignment of this CK-B gene to the same telomeric band on human chromosome 14 (14q32) previously shown to contain the IgH locus (27) . This interpretation is strengthened by the fact that five independent human-mouse hybrids retain an incomplete chromosome 14 but do not contain human CK-B1 sequences or IgH sequences. These hybrids, however, all express nucleoside phosphorylase, a long arm marker for this chromosome (data not shown).
In a second group of hybrids, the 2.7-and 5.0-kb human Pst I bands, and the 9-kb human Hind III band were observed to segregate concordantly to chromosome 16 (Table I ). These sequences have been designated as CK-B2. The 24-kb human Bam HI band also appeared to be present in this second group of hybrids, but the weak band intensity and poor separation from homologous bands prevented unambiguous chromosomal assignment of this band. One particular somatic cell hybrid retained a chromosome 16 with a deletion of most of the long arm. A long arm marker, diaphorase-4 (16qI2-q2 1), is not expressed in this hybrid, but a short arm marker, phosphoglycolate phosphatase (16pl2-pl3), was detected. This hybrid retained the active human metallothionein gene complex (28) and the CK-B2 sequence. Four other hybrids from another series retained human diaphorase-4, active metallothionein genes, and the CK-B2 sequence, but lacked phosphoglycolate phosphatase activity (data not shown). These results localize the CK-B2 sequence to the region 16pl3-16q21. Discussion (35, 36) . The specific sites involved in the phosphate group transfer or in nucleotide binding have not been determined. Specific modification of chicken CK-MM or BB with proteinase K and pronase E cleaves the enzyme -50 amino acids from the carboxyl end, generating two fiagments that result in the loss of 90% enzyme activity (37) . This cleavage has been determined to occur between alanine residues 328 and 329, which is 45 residues downstream from the conserved cysteine site. Of interest, the carboxyl terminal-modified, proteolytically inactivated, enzyme is still able to establish proper subunit-subunit interactions suggesting that the subunit recognition domain is at a distance upstream from the cleaved residues. This subunit recognition domain is currently undefined, but highly conserved regions (e.g., amino acids 183-223) between both M-and B-genes exist and could be of importance in such subunit interactions. The ability to generate hybrids between the BB isoenzyme of the rabbit or ox with the analogous invertebrate enzyme arginine kinase from the sea cucumber (Holothuria forskalh) (38) underscores the potential functional importance of these subunit interactions.
The use ofa B-specific sequence has also allowed us to explore the complex genomic pattern ofthe CK related family of genes. We did not observe any evidence for amplification or rearrangement of these genes in SCLC. We did, however, demonstrate that there are at least two CK-B homologous sequences in human DNA on different chromosomes. Prior chromosomal mapping of CK-B activity by starch gel electrophoresis of somatic cell hybrid lysates localized the gene to chromosome 14 (39, 40) . Other authors, however, concluded that the presence of other chromosomes, in particular chromosome 17, were required in combination with chromosome 14 for CK-BB expression (41, 42) . Although this latter observation was not confirmed (27) provisional assignment of a CK-B locus has also been to chromosome 17 (43 The presence of human sequences hybridizing with a human CK-B specific cDNA probe is correlated with the presence or absence of specific human chromosomes in 36 human-hamster and 38 humanmouse hybrid cell lines in column 1 or 6 human-hamster and 38 human-mouse hybrids in column 2. Discordancy represents either the presence of a specific human chromosome in the absence of human CK-B hybridizing sequences or the presence of these sequences despite the absence of the chromosome in that hybrid. The percent discordancy represents the sum of these numbers divided by the total number of hybrids examined. The chromosome giving the lowest discordancy (i.e., 0%) contains the CK-B specific sequence. Column 1 indicates discordancy with the 2.4-and 7.7-kb human Hind III bands, the 0.95-and 1.55-kb human Pst I bands, and the 8.4 kb human Bam HI band (i.e., CK-Bl sequence). Column 2 indicates discordancy with the 9.0 kb human Hind III and the 2.7 and 5.0 kb human Pst I bands (i.e., CK-B2). * There were no discordancies between hybrid cells retaining chromosome band 14q32 and CK-B1 hybridizing sequences, but there were 10 discordancies (14%) involving portions of chromosome 14 not containing this band (see text).
may be subject to influences of outside regulatory forces at the transcriptional or posttranscriptional level. In addition, such analyses would not detect genes that were not functional in the hybrid environment. Our studies establish the mapping of a CK-B gene to chromosome 14q32, and have also found evidence for a second CK-B gene or gene-related sequence on chromosome 16. B-subunit:B-subunit mixing experiments (44) and high resolution two-dimensional gel electrophoresis (45) have suggested the presence of two functional CK-B genes in certain species. In addition there is recent evidence for sequence heterogeneity among chicken CK-B cDNA clones in their 3' untranslated and coding regions again suggesting either the presence oftwo distinct genes or the occurrence of alternative processing (46) . Since it is known that the CK-B gene on chromosome 14, which we call CK-B1, is functional in rodent-human hybrids, the precise role and functional activity of the CK-B gene on chromosome 16 (here designated CK-B2) needs to be established. While it is conceivably only a CK-B-related gene or pseudogene, it is also possible that it represents a CK-B enzyme activated during ontogeny in a regulated fashion, distinct from activation of CK-B1. We have recently cloned the CK-Bl locus on chromosome 14 and have observed the appropriate organization of an active gene. It will be of interest to use this clone and the two independent, high frequency Eco RI polymorphism sites that we have identified to explore allelic distribution and activation of this locus in neuroendocrine tumors.
